Physiomics Management
Management criteria checks 2/4
Physiomics' CEO is Peter Sargent, appointed in Sep 2023, has a tenure of 1.33 years. total yearly compensation is £93.34K, comprised of 78.2% salary and 21.8% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth £3.33K. The average tenure of the management team and the board of directors is 2.4 years and 2.8 years respectively.
Key information
Peter Sargent
Chief executive officer
UK£93.3k
Total compensation
| CEO salary percentage | 78.2% |
| CEO tenure | 1.3yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2.4yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year
Nov 15
Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair
Nov 17Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet
Nov 16What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?
Feb 08
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | UK£93k | UK£73k | -UK£609k |
Compensation vs Market: Peter's total compensation ($USD115.99K) is below average for companies of similar size in the UK market ($USD346.45K).
Compensation vs Earnings: Insufficient data to compare Peter's compensation with company performance.
CEO
Peter Sargent (46 yo)
1.3yrs
Tenure
UK£93,335
Compensation
Dr. Peter Joseph Sargent is Chief Operating Officer of Physiomics Plc from September 04, 2023 and serves as its Chief Executive Officer and Director from January 22, 2024. He joined Physiomics Plc in Septe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, COO & Director | 1.3yrs | UK£93.34k | 0.23% £ 3.3k | |
| Co-Founder & Member of Scientific Advisory Board | no data | UK£2.63k | no data | |
| Head of Finance & Company Secretary | 8.7yrs | no data | no data | |
| Head of Business Development | 3.4yrs | no data | no data | |
| Head of Biostatistics | 1.3yrs | no data | no data | |
| Head of Quantitative Pharmacology & Data Science | less than a year | no data | no data | |
| Consultant & Member of Scientific Advisory Board | 9.4yrs | no data | no data | |
| Consultant & Member of Scientific Advisory Board | no data | no data | no data |
2.4yrs
Average Tenure
56yo
Average Age
Experienced Management: PYC's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, COO & Director | less than a year | UK£93.34k | 0.23% £ 3.3k | |
| Co-Founder & Member of Scientific Advisory Board | no data | UK£2.63k | no data | |
| Consultant & Member of Scientific Advisory Board | 9.4yrs | no data | no data | |
| Consultant & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 2.3yrs | UK£20.00k | no data | |
| Independent Non-Executive Director | 2.8yrs | UK£20.00k | no data | |
| Non-Executive Chairman | 8.7yrs | UK£67.43k | 0.93% £ 13.7k |
2.8yrs
Average Tenure
57yo
Average Age
Experienced Board: PYC's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 04:18 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Physiomics Plc is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yi-Ling Liu | Hybridan LLP |
| Alexander Pye | WH Ireland Limited |